Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 4, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Antimicrobial surfaces to reduce bacterial build-up on medical instruments

International Day for Biological Diversity – May 22, 2021

Diabetic patients and Covid-19 pandemic

Antimicrobial surfaces to reduce bacterial build-up on medical instruments
  • BiotechToday
  • World

Antimicrobial surfaces to reduce bacterial build-up on medical instruments

bioxone May 22, 2021May 22, 2021

Aakancha Shaw, St. Xavier’s College, Kolkata

The researchers of Monash University have developed new antimicrobial surfaces that can efficiently reduce the formation of bacteria on medical instruments, including urinary catheters, and hence can reduce the risk of patient infection while in hospital.

This world-class study proves the ability of these 3D-engineered surfaces in preventing the formation and growth of colonies of microorganisms like Escherichia coli (E.coli), Pseudomonas aeruginosa, and Klebsiella pneumoniae. These are the three most common types of urinary tract bacterial infections (UTIs) associated with catheters. The study team was led by Dr. Victor Cadarso, Department of Mechanical and Aerospace Engineering, and the Center to Impact AMR, Monash University. Engineered surfaces with 3D smooth micro features instead of the traditional sharp cross-sectional ones were a breakthrough to reduce the potential for harmful bacteria to attach to the surfaces in huge numbers.

The surfaces that were tested were found to show a reduction in both attachments of bacteria and biofilm formation. One of the surfaces that were considered, P01, presented excellent properties against E.coli(55 percent fewer bacterial cells attached, 53 percent fewer microcolonies being formed), K.pneumoniae(69 percent fewer bacterial cells attached, 77 percent fewer microcolonies being formed), and P. aeruginosa (68 percent less bacterial cells attached, 66 percent fewer microcolonies being formed). Urinary tract infections (UTIs), caused due to urinary catheters, are one of the most common types of healthcare-associated infections and have been identified by the World Health Organization (WHO) as an urgent global health threat. Approximately 13000 people die each year from UTIs and around 7 Lakh people die from related antimicrobial resistance infections. This is because of the resistance of superbugs to current sterilization practices and to antibiotics. 

Using E.coli the researchers found bacterial cells that form on surfaces, mostly on the sharp corners. Hence, by successfully removing these sharp features, the bacteria can no longer colonize the surface effectively. This same effect was demonstrated for the two other pathogens- Pseudomonas aeruginosa and Klebsiella pneumoniae. in this study. Surfaces such as catheters and ventilators are a significant source of microbial spread and associated infections. So, a smarter approach would be physically altering the architecture of these surfaces instead of using chemical agents. The former is a more effective strategy for fighting antimicrobial resistance

The bacterial colonization of surfaces takes place gradually. As bacteria attach to a surface, cellular responses are triggered and a few rounds of cell division results in the formation of microcolonies of such bacterial cells. After this successful colonization, the bacterial colonies form a biofilm. Biofilm is a large population of bacteria in a matrix that binds together and protects the cells from the immune system. This might create a superbug that can cause long-term health complications for patients. The researchers found out that the sharp corners of various medical instruments provide hiding spots for the bacteria and by smoothing these corners, the bacteria would get no place to hide. 

Hence, researchers developed such great strategies for the prevention of bacterial colonization of surfaces like catheters, and is very important to prevent the potential spreading of harmful diseases.

Also read: International Day for Biological Diversity – May 22, 2021

Reference- Three-Dimensional Micropatterning Deters Early Bacterial Adherence and Can Eliminate Colonization

  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Related

Tagged Antibiotic antimicrobial bacteria biofilm Catheter superbug UTI

2 thoughts on “Antimicrobial surfaces to reduce bacterial build-up on medical instruments”

  1. Pingback: Diabetic patients and Covid-19 pandemic - BioXone
  2. Pingback: C28 : Controls the side effects of drugs on the Heart - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Diabetic patients and Covid-19 pandemic

bioxone May 22, 2021

Husna, Amity University Kolkata COVID-19 is a highly contagious viral infection that can mainly affect the respiratory system. It is caused by the SARS-CoV-2 virus which has the ability to mutate. Due to frequent mutations, the COVID-19 strains are highly virulent and tend to infect more rapidly, leading to a rapidly evolving pandemic. The impact […]

Diabetic

Related Post

  • BiotechToday
  • World

Albumin as an immunity booster and human sperm capacitator

BioTech Today June 25, 2021June 24, 2021

Soumya Shraddhya Paul, Amity University Noida From the time pH first came into existence it has been playing a really important role in nature. Researchers have seen that, for our body to work properly it’s very important to maintain the intracellular pH. Another very fascinating term related to this is human voltage-gated proton channels (hHv1) […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • BiotechToday
  • World

The role of certain RNA Helicases in lymphomagenesis

BioTech Today September 3, 2021September 3, 2021

Parnad Basu, Amity University Kolkata Lymphoma is a type of cancer that occurs in the human lymphatic system- the network that fights the body’s diseases. It includes the lymph nodes, bone marrow, spleen, and the thymus gland. There are mainly two major subtypes of lymphoma, Hodgkin’s lymphoma and non-Hodgkin’s lymphoma (NHL). Hodgkin’s lymphoma has Reed-Sternberg […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • BiotechToday
  • India

Oxford-AstraZeneca: CDSCO approved after several debates

bioxone January 2, 2021January 2, 2021

Camelia Bhattacharyya, Amity University Kolkata When dealing with treatments relating to human health, we need to take care of two things: i.) the cure should be developed on the basis of all criteria including the majority of the population, and ii.) side-effects should be absent or negligible. Any drug or vaccine to be identified safe, […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy